Inge Van De Walle

6PUBLICATIONS
30CO-AUTHORS
Proteins and peptidesMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody.

|Aug 16, 2025
Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart.

Inge Van de Walle, Laura Bracke, Heidi Gytz Olesen

|Jan 26, 2023
Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNF.

Kai Ling Liang, Juliette Roels, Marieke Lavaert

|Dec 16, 2022
Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model.

Clare I Campbell, Rhona McGonigal, Jennifer A Barrie

|Nov 11, 2021
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy.

Kevin Budding, Lill Eva Johansen, Inge Van de Walle

|Sep 12, 2020
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.

Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon

Pageof 1

Frequent Collaborators

2 joint publications

Gregers Rom Andersen

2 joint publications

Erwin Pannecoucke

2 joint publications

Hans de Haard

2 joint publications

Laura Bracke